Skip to main content

Table 3 Peri-operative patient characteristics split according to whether they fulfilled criteria for vasoplegia, or not

From: The need for post-operative vasopressor infusions after major gynae-oncologic surgery within an ERAS (Enhanced Recovery After Surgery) pathway

 

No vasoplegia, median IQR (n = 259)

Vasoplegia, median IQR (n = 61)

p value

Pre-op

 Age (years)

66 (55.25–74)

70 (58–77)

0.209

Weight (kg)

70 (60–83)

61 (54.5–70)

<0.001

 Pre-op Hb (g/l)

124 (111–134.75)

119 (104–131)

0.053

 Pre-op albumin (g/l)

42 (39–44)

42 (39.25–44)

0.433

 Pre-op chemotherapy no. (%)

78 (37%)

20 (39%)

0.872

P-POSSUM mortality

4.85(1.7–13.2)

16.9 (7.0–23.6)

<0.001

P-POSSUM morbidity

70.9 (37.0–88.7)

92.4 (80.2–95.3)

<0.001

Intra-op

IV fluid given (ml)

2000 (1275–3000)

3500 (2500–4650)

<0.001

Blood transfusion (ml)

0 (0–0)

0 (0–268.5)

0.019

Surgical_EBL (ml)

600 (300; 1200)

1450 (925–2000)

<0.001

Post-op

Cumulative fluid balance (ml)

2760 (1572–4186)

4675 (1854–6549)

0.001

 Hb on POD1 (g/l)

108 (99–118)

111 (100.5–118)

0.396

Hb drop (g/l)

17 (6–24.8)

9 (− 7–21)

0.01

Albumin POD1 (g/l)

29.5 (26–32)

27 (23–30)

<0.001

Albumin drop (g/l)

13 (9–15)

13 (11–17.8)

0.046

CRP POD1 (mg/l)

61 (40–95)

93 (48.5–131)

0.002

 Epidural use, no. (%)

179 (69%)

50 (82%)

0.058

ICU LOS (days)

1.9 (1.05–2.88)

2.94 (2.22–3.88)

<0.001

Hospital LOS (days)

5.08 (4.01–6.49)

6.8 (5.78–8.17)

<0.001

 Mortality at 1 year, no. (%)

10 (5%)

4 (8%)

0.485